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Abstract
Background: The literature on sexual orientation disclosure is arguably one of the most developed in the field of
lesbian, gay and bisexual (LGB) people in healthcare in English speaking countries however, relatively little research
has been conducted into disclosure in cancer care. Studies have been mainly undertaken in primary care where
distinct circumstances pertain and where the benefits of disclosure include obtaining appropriate health
information, treatment advice and avoiding misdiagnosis.
Methods: We conducted an in-depth qualitative study primarily recruiting patients through oncology care in
hospital settings and through LGB community cancer support groups. Data were gathered through semi-structured
interviews with 30 LGB patients with different cancer types.
Results: Data were analysed using thematic analysis and interpreted and interrogated through salutogenesis theory
which offers a useful lens through which to consider the health promoting effects of sexual orientation disclosure
in cancer care. We present three themes as part of the analysis: Authenticity as a driver for disclosure in cancer care,
Partners as a (potential) salutogenic resource and Creating safe, healing environments conducive to disclosure. The
findings are reported and discussed in relation to three inter-related concepts from current salutogenesis theorising
including a sense of coherence, generalised resistance resources and healing environments which can facilitate
sexual orientation disclosure.
Conclusion: Our findings enable a more nuanced approach to understanding disclosure in this context. This study
contributes to the literature through its articulation of the salutogenic potential of disclosure (if responded to
appropriately) for LGB patients as individuals, in relationship to their partners or carers and the role of creating a
visible healing-oriented optimal environment to promote quality of life and recovery.
Keywords: Disclosure, Generalised resistance resources: healing environments, Salutogenesis, Sense of coherence,
Sexual orientation, Qualitative methods
Background
The literature on sexual orientation disclosure is argu-
ably one of the most developed in the field of lesbian,
gay and bisexual (LGB) people in healthcare in English
speaking countries. Yet despite its salience, there has
been relatively little theorising of its potential benefits.
Disclosure involves the communication of one’s sexual
orientation to the clinician providing care. The
significance of disclosure for the health and wellbeing of
LGB patients lies in its association with improved psy-
chological well-being [1]; however, findings about better
physical health outcomes are more mixed [2]. Disclosure
to health professionals brings multiple benefits including
obtaining appropriate health information, treatment
advice and avoiding misdiagnosis. Those who are open
about their sexual orientation typically report greater
levels of comfort with their healthcare providers and
increased satisfaction with care [3].
Research in disclosure has been mainly conducted in
primary care where distinct circumstances pertain;
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disclosure is often facilitated by the longevity of the rela-
tionship, it is usually one to one, and the interaction is
typically patient initiated [4]. Moreover, LGB people
often engage in a number of proactive strategies to iden-
tify a General Practitioner (GP) known to provide LGB
affirmative care [5]. The timing of disclosure may also
differ; in primary care disclosure is said to most often
occur early in the relationship [6]. However, in cancer
care, the circumstances may not be so conducive: the
patient is in a potentially unknown environment, the
consultation is often a formal and hierarchical one with
the doctor leading the communication; moreover, at this
early consultation, a patient may receive a diagnosis of a
life-threatening condition.
Relatively little research about revealing a sexual mi-
nority identity has been undertaken in cancer care [7–9].
Recent research has used Meyer’s [10] concept of Minor-
ity Stress Theory (MST) as an explanatory framework to
understand how expectations of rejection, experiences of
discrimination and internalised homophobia may affect
the likelihood of disclosure in cancer care [11]. The
study highlighted both the effects of felt and enacted
stigma and some of the strategies that LGB individuals
use around the disclosure or performance of their sexual
identity to avoid or deflect actual and/or anticipated
conflict and hostility. In a systematic review, disclosure
was also considered through the lens of minority stress
theory: fear of discrimination, including receiving poor
or unequal care, feeling embarrassment or humiliation
after disclosure; concerns about confidentiality and the
recording of sexual orientation in medical records were
seen to constitute barriers to disclosure [4].
Taken together, these contextual factors suggest that
the nature of disclosure in cancer care has a number of
differing characteristics than in primary care and re-
quires specific research enquiry. Findings may also go
some way in explaining the lower rates of disclosure in
hospital settings in comparison to those found in pri-
mary care [7]. In light of the above, the aim of this study
is to explore the conditions under which a sample of
British LGB cancer patients revealed their sexual orien-
tation in hospital settings to enable a more nuanced
approach to understanding disclosure in this context.
Method
Theoretical framework: disclosure as salutogenesis in LGB
cancer care
Cancer has repercussions not only for people’s physical
and psychological health, but also their identity and
social well-being [12]. In approaches with a pathogenic
orientation, a range of (typically unpleasant) medical
treatments, including surgery, radiotherapy, hormone
treatments and chemotherapy, may be used to remove
signs of disease from the body. Quality of life and a
resumption of activities that were the norm before illness,
however, go beyond the absence of disease. Moreover,
people’s health outcomes (including those specifically as-
sociated with cancer) are also affected by what Smith [13]
has labelled ‘social pathogens’. These include factors such
as health inequalities, stigma and prejudice, and poorly
resourced healthcare that may lead members of certain
social groups (such as the economically disadvantaged
and members of black and minority ethnic communities
as well as LGB individuals) to experience not only poorer
health and well-being but also poorer quality, culturally
insensitive care with its associated sequelae (lower satis-
faction and participation in healthcare).
Whilst the current study sought to illustrate the vital
role of such social pathogens in understanding British
LGB people’s experiences of cancer care, our research
also set out to recognise the resources that many LGB
people utilise to improve their care pathway. It identifies
some structural changes that can serve to synergise with
these efforts, potentially leading to cancer care which is
genuinely LGB affirmative. A key theoretical component
here is ‘salutogenesis’, which as a health promoting
orientation, underpins holistic care by addressing an in-
dividual’s social, psychological and personal factors,
alongside the physical signs of illness [12], and identifies
what Antonovsky [14] labels ‘salutary factors’ which can
promote healing. At a simple level this may include
identifying and nurturing both personal resources (such
as resilience) and collective resources (such as social
support from LGB friends and peers) and how these are
employed and interact with the environment the individ-
ual is navigating.
Central to many understandings of salutogenesis is
understanding how improved health may be generated
by building on a person’s sense of coherence (SOC),
which refers to how people view their lives, alongside
their efficacy in utilising generalised resistance resources
(GRR), which include ‘self-esteem, preventive health
orientation, social support and cultural capital’ [15].
Movement towards the ‘health pole’ of the ‘ease/dis-ease
continuum’ [14] is promoted by the presence of GRR.
Prior research has shown how LGB patients some-
times compartmentalise, or fail to disclose, their iden-
tities in healthcare settings [11]. For LGB patients with
cancer, their SOC may include a holistic sense of self
where they are able to be authentic in clinical interac-
tions. Essentially coming out as LGB in cancer care illus-
trates a person’s self-acceptance and sense of coherence.
In addition, taking pride or confidence in disclosure can
be seen as a resistance resource. Integrating these mul-
tiple functions and meanings of disclosure provide a
rationale for placing disclosure as a central process in
understanding salutogenesis for LGB people receiving
oncology (and potentially other forms of ) healthcare.
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Research in this field is flourishing with a growing lit-
erature on salutogenic approaches to health including
work on older people [16], cancer patients [17] and HIV
positive patients [18]. In addition, applied salutogenesis
theorists have written extensively on how the policies,
practices and structures of contemporary healthcare
provision have the potential to create ‘optimal healing
environments’ characterised by factors such as empath-
etic and compassionate care and cultural competence
and sensitivity [19]. Therefore, both drawing on and con-
tributing to this literature, this study considers the role of
disclosure through the lens of salutogenesis theorising. In
particular we consider the possibilities for promoting a
sense of coherence, the potential role of partners in pro-
viding generalised resistance resources and salutogenic
healing environments in LGB cancer care. The research
questions which informed this study are:
What are the potential salutogenic factors that LGB
cancer patients can draw on and how can this be
enhanced in oncology care?
How is disclosure a potentially salutogenic resource
for better coping with cancer for LGB people?
Design
This qualitative study involved individual semi-structured
interviews to elicit in-depth accounts of LGB people’s expe-
riences of disclosure and nondisclosure, their interactions
with professionals and their perceptions of good cancer
care. The reporting for this study is informed by the 32
item COREQ criteria for qualitative health research [20].
Public and patient involvement in the design of this
study
Significant public and patient involvement (PPI) work
was undertaken in developing the present research and
to ensure it represents research with rather than on LGB
people affected by cancer. PPI events were held in 2
British cities and open-ended questionnaires were dis-
tributed to participants at a LGB cancer inclusion event
and at a structured discussion workshop at the research
team’s university. In total 26 LGB people who have expe-
rienced cancer contributed views, 13 in a written form
and 13 verbally, to the design and scope of the final
study (Please see Additional file 1 for details).
Participants
The inclusion criteria were that participants had been
diagnosed with any form of cancer within the past five
years and self-identified as a lesbian, gay man or bisexual
person. Participants were recruited through non-
probability methods, by displaying research posters
which included a contact mobile number, in the clinic
waiting rooms of five oncology departments in various
parts of England and also through the online forum of a
cancer charity, LGB social media and local radio inter-
views. Three potential participants withdrew from the
study, due to a worsening of their condition, before data
collection commenced.
Procedure
Materials promoting the study were made available at
participating hospitals in waiting rooms and through the
websites of cancer charities and social media. Potentially
interested participants contacted the research assistant
and an initial discussion took place about the aims and
purpose of the study. Participants who confirmed that
they wished to take part were sent a participant informa-
tion sheet, provided informed consent and gave brief
demographic information. Interviews were guided by a
semi-structured schedule which had been first piloted
and was used flexibly (see Additional file 2: Table S1).
Interviews lasted between 1 and 2 h and took place in a
location of participants’ choice, mainly their own homes
or in university or other private offices, and were con-
ducted by one of four experienced interviewers, (three
women and one man) all of whom had received good
clinical practice training in 2017. No-one else was
present for the duration of the interview. The interviews
were audio- recorded and transcribed verbatim by a pro-
fessional transcriber. Data were stored in a password
protected file on a secure server.
Ethics and research governance
A three stage procedure of ethical approval and research
governance is required for research conducted in the
NHS. Ethical approval was first obtained from the
Principal Investigator’s academic institution, De Mont-
fort University, Health and Life Sciences, Research
Ethics Committee. Secondly, approval was awarded
through the Integrated Research Application System to
enable a study to be conducted in UK hospitals. Thirdly,
NHS Research & Development, which monitors research
governance procedures and requires a comprehensive
audit trail for each hospital site was obtained. Ethical
approval was conditional upon NHS training of all mem-
bers of the research team. All data were securely stored
and participants’ names and other details have been
appropriately anonymised.
The study was conducted in accordance with the
British Psychological Society (BPS), Code of Research
Ethics [21]. Participants were provided with full informa-
tion to enable them to take part and we obtained written
informed consent. To ensure confidentiality and privacy,
participants were allocated a pseudonym; a distress
protocol was implemented and participants had the right
to pause, reconvene or terminate the interview.
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Method of analysis
Our analytical approach is informed by thematic
analysis [22]; this is a flexible method which is com-
monly used in health and psychological research. We
paid attention to the meaning-making of participants
in an iterative process. At phase one, at an early
stage in the data-collection, four of the research
team independently read a subset of transcripts. We
met together to discuss our individual interpretations
of the data and this immersive reading involved ini-
tial identification of patterns in the data. At phase
two, two of the authors (JF and IW) developed a
template to identify these recurring themes and pro-
duced an overarching framework. As the analysis
developed we recognised that the concept of saluto-
genesis, defined by Jonas et al. [19] as ‘the process
of healing and health creation’ provided a useful and
relevant lens with which to interrogate and interpret
the data at the latter stages of theme development
and refinement. In this paper we present three
themes: ‘Authenticity as a driver for disclosure in
cancer care’, ‘Partners as a (potential) salutogenic
resource’ and ‘Creating safe, salutogenic healing envi-
ronments conducive to disclosure’. The sequencing of
our themes moves from individual through more
relational and systemic influences on disclosure.
Concepts from classic and current thinking around
salutogenesis are applied throughout.
Results
Thirty participants took part in the study (see Table 1).
All participants identified as cis-gender with 18 men and
12 women participating. Of the men, 15 identified as gay
and 3 as bisexual. Of the women 11 identified as lesbian
and 1 as queer. Twenty participants were partnered and
6 were single. All relationships were with a same-sex
partner apart from one man who was married to a
woman and identified as bisexual. Participants’ ages
ranged from 24 to 77 years. The cancers they had experi-
enced were prostate [15], breast [9], lymphoma [2],
thyroid [1], ovarian [1], bowel [1] and skin [1].
Authenticity as a driver for disclosure in cancer care
Normative assumptions underpinning healthcare are
that the patient is heterosexual - their identity/ sexu-
ality does not require articulation - in most interac-
tions it is simply and implicitly presumed [23]. For
LGB patients, authenticity is achieved by a positive
response to the disclosure of sexual orientation and a
shared recognition by both patient and professional
that the whole self is relevant to health, rather than a
focus on merely treating the disease. However, a mi-
nority of participants chose not to disclose their
sexual orientation to health professionals arguing that
it was not related to their care:
I didn’t feel any need to tell them that I am gay
because it was in my view irrelevant to treatment. But
they certainly didn’t ask me and why would they?
(Bob, gay man, prostate).
Here, Bob, employs a pathogenic orientation to his
cancer care. He implies that his non-disclosure is an
active choice that allows all parties to concentrate on the
biomedical ‘business’ of treatment and recovery without
‘irrelevant’ distractions. This construction is further rein-
forced by his rhetorical question.
However, other participants said that coming out to
health professionals early in the relationship enabled
them to decide how and when to disclose. By choosing
the timing or circumstances of disclosure, Noel said that
it took the stress away from a subsequent moment
where he may have felt more vulnerable. Moreover, for
him, disclosure enabled ordinary conversations which
facilitated everyday social interaction:
almost invariably…you talk just for filling time about
your family life, …And if you’re just holding that just
one bit of information back it gives a little bit of
stress. …. I made the decision at the outset, I’d said
that I was gay (Noel, gay man, prostate).
Relating to salutogenesis, taking control of disclosure
connects to the key concept of sense of coherence
wherein Noel uses voluntary and self-initiated disclosure
to manage both current and future potentially stress-
inducing situations (Eriksson, 2017). Others voiced more
empathetic motives for disclosure arguing that they facil-
itated authentic relationships with others:
It wasn’t a case of us being asked… we volunteered
the information because it makes other people feel at
ease (Davina, lesbian, ovarian).
Other participants said that disclosure facilitated holis-
tic care; Rudy clearly identified the benefits of being
open with health professionals, saying that being gay is
the first thing that they should know about him:
As far as I’m concerned that unless you are open about
your sexuality you can’t expect to be treated
holistically… If I am on my own I make sure that
people know. I think it’s important for other people…
who might not be so confident (Rudy, gay man, breast).
In contrast to participants like Bob, Rudy articulates a
perspective that disclosure is fundamental to holistic or
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person centred care. Such an approach, in salutogenesis
theorising, might be understood as ‘facilitating healing’
rather than simply ‘being treated’ [19]. He also appears
to take pride as a role model for other less self-assured
LGB people.
Many participants addressed the potential presump-
tion of heterosexuality in initial interactions with cancer
specialists, recognising that staying ‘closeted’ would both
engender feelings of anomie and deny them access to
full psychosocial care:
I did say very early on that I was gay and I didn’t want
people to assume that I was straight…because it
makes me feel alienated. They are not actually
engaging with the real me (Terry, gay man, prostate).
Because of the prevalence of prostate cancer amongst
our gay and bisexual participants, our male participants
were mostly over the age of 55. Tim reflected that gay and
bisexual men who came of age at the time of the 1967
Sexual Offences Act represented a generation that is ‘not
comfortable in own its skin’ and hold deeply ingrained at-
titudes ‘that you can’t be yourself ’. However, in choosing
to disclose, he believes he has received superior care:
I have been able to have a smoother journey through
this because I didn’t keep anything hidden (Tim,
bisexual man, prostate).
Whilst taking active control of disclosure early in their
cancer pathway was the most common narrative, a small
Table 1 Participants’ demographic characteristics
P # Pseudonym Identity Relationship status Age Cancer site
1 Fiona Lesbian partnered 55–64 Breast
2 Julian Gay man partnered 55–64 Prostate
3 Rudy Gay man partnered 65+ Breast
4 Bob Gay man partnered 65+ Prostate
5 Nadia Lesbian partnered 35–44 Breast
6 Tom Gay man partnered 45–54 Prostate
7 Robert Bisexual man partnered (with a man) 45–54 Prostate
8 Daniel Bisexual man married (with a woman) 55–64 Prostate
9 Jeremy Gay man partnered 65+ Prostate
10 Steph Queer partnered 25–34 Thyroid
11 Corinne Lesbian partnered 55–64 Breast
12 Ellie Lesbian single 65+ Breast
13 Lou Lesbian partnered 24–34 Breast
14 Robin Gay man partnered 45–54 Prostate
15 Terry Gay man single 65+ Prostate
16 Quentin Gay man partnered 55–64 Prostate
17 Miranda Lesbian partnered 35–44 Breast
18 Linda Lesbian partnered 45–54 Breast
19 Tracy Lesbian partnered 45–54 Bowel
20 Davina Lesbian partnered 55–64 Ovarian
21 Karl Gay man partnered 55–64 Prostate
22 Tessa Lesbian single 45–64 Breast
23 Oliver Gay man partnered 35–44 Lymphoma
HIV+
24 Gertrude Lesbian Single 65+ Lymphoma
25 Noel Gay man Newly partnered 65+ Prostate
26 Tim Bisexual man Partnered (male) 65+ Prostate
27 Nigel Gay man Single 35–44 Prostate
28 Liam Gay man Partnered 35–44 Skin
29 Craig Gay man Partnered 65+ Prostate
30 Norman Gay man Single 55–64 Prostate
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number of participants discussed how their cancer diag-
nosis represented a catalyst to a more open and ‘authen-
tic’ way of managing their sexual identity. For Robert,
who identified as bisexual, a supportive new relationship
with a male partner, combined with therapeutic support
and led to a watershed moment:
I am completely open now about my sexuality which I
wasn’t before when you have only got a certain
amount of time…what is important is being honest
and authentic (Robert, bisexual man, prostate).
As acknowledged above, a minority of participants saw
their sexual orientation as irrelevant to their cancer care.
They talked of not wanting the ‘label’ of sexual orienta-
tion or of feeling that they have received or should re-
ceive the same quality of care as do other patients
without a need to voice being lesbian, gay or bisexual.
Other participants argued, however, that openness about
their sexual orientation meant that they received appro-
priate psychosexual advice for side-effects of prostate
cancer such as erectile dysfunction while others were
motivated to disclose because it creates a smoother or
more humane relationship. These participants said that
disclosure enabled professionals to engage with them in
an holistic and authentic fashion and gain the whole pic-
ture of their lives. Disclosure also provided a sense of
coherence and self-efficacy which facilitated their naviga-
tion of their cancer journeys.
Partners as a (potential) salutogenic resource
Having a partner or carer, and particularly one who at-
tends medical appointments, makes it easier for partici-
pants to disclose (and thereby gain validation for the
relationship). In some cases explaining their presence
obliges the patient to disclose their sexual orientation.
Here, we explore how partners may comprise a saluto-
genic resource if their supporting role is recognised and
encouraged; conversely, their role may be invalidated if
overlooked, or dismissed by healthcare professionals.
Four-fifths of participants in our sample were in a rela-
tionship, and all (but one of them) were accompanied by
their partner to hospital consultations and treatment. Al-
though Robin had not explicitly disclosed his sexual
orientation, the healthcare professionals involved in his
care implicitly validated their relationship:
we haven’t just come out and said we are gay, we are
married but …the way they talk, oh [you] are
together. And they don’t change their attitude, it does
make you feel at ease and it does help you with the
course of action. They appreciate he is here for me
(Robin, gay man, prostate).
He draws attention to the benefit of his partner’s
involvement in making decisions about treatment op-
tions or ‘course of action’. In a similar vein, Steph recog-
nises that disclosure enables health professionals to
‘treat me as a whole person’ within an ecological frame-
work including ‘family, support network and partner’:
People don’t get the full picture of your life otherwise
and who is supporting you (Steph, queer, thyroid).
A partner’s presence also provides the opportunity to
disclose without having to make a direct statement
about oneself, when there is no other context in which
to place such a statement. This strategy of active disclos-
ure links to the forthright approach adopted by many
participants in theme one and to the concepts of
authenticity and sense of coherence. A number of partic-
ipants talked about staff being ‘fine with it’, ‘not uncom-
fortable or uneasy’. Others talked about interactions
with staff where they felt, rather than a fairly passive
acknowledgement, that the nurse had actively validated
their relationship, in this instance by a positive compari-
son with her own:
(she)…pushed me down to the theatre and she went
“have you been together long?” and I said oh 22 years…
and she went “good lord that’s longer than me and my
husband- you deserve a medal”. So, perfectly accepting
and perfectly friendly. (Liam, gay man, skin).
Nadia talked about an interaction which illustrates
(tacit) knowledge of generalised resistance resources [24]
wherein the breast care nurse actively extends her
(Nadia’s) coping resources, promoting her social support
and paying attention to what is working well:
My marvellous breast care nurse …said you get your
wife to make you an Ovaltine in the evening, get her
to bring it up to you in bed. And it was the way that
she so naturally said that, it was absolutely lovely, it
was moving because we never really had an explicit
conversation about that (Nadia, lesbian, breast).
Reflecting on the nurses’ involvement of his partner in
planning his care, Karl describes a proactive approach in
which his partner is recognised as a resource to promote
his health, in addition to showing concern for his part-
ner’s own health as a carer:
they ask him how he is…they talk to him about him
as well (Karl, gay man, prostate).
In contrast to these salutary/health-promoting experi-
ences, participants talked of interactions in which their
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significant relationship was invalidated (and the potential
was missed for a salutogenic approach): partners were
assumed to be siblings, parents or friends. In some
instances, the couple had attended appointments to-
gether sitting in a waiting room over several weeks and
were ignored, while they perceived that heterosexual
couples in a similar situation were engaged with. Some-
times a professional would make assumptions, or ignore
information rather than ask an open question for clarifi-
cation. The partners of two female participants were
metaphorically shut out by a curtain during a biopsy
because the health professional told them they were just
‘good friends’, while a gay man’s partner was whispered
about as if he were a secret.
A number of participants talked about the legal recog-
nition afforded to their relationship by the Civil Partner-
ship Act 2004 and/or the Marriage (Same-Sex Couples)
Act 2013. They claimed legitimacy for their relationships
by introducing their partner as their husband or wife,
but this was disputed by some health professionals. For
example, one woman said:
I was admitted there was a form (and) the woman …
argued that we must be civil partners that we couldn’t
be married. (It) went on for slightly longer than was
comfortable. Presumably she hadn’t heard…it had
changed now ….. That somehow …we were mistaken
that we were married (Lou, lesbian, breast).
Often, reflecting on the interactions they had, they com-
pared the treatment of their partner with what they saw
offered to others, where heterosexual couples did appear
to be involved. But at other times, they did not know
whether they were treated differently to other couples.
In cancer care, patients are commonly accompanied
by their spouse and can often help to process informa-
tion and support them emotionally if they should receive
bad news. However, in the following instance, the doc-
tor’s discomfort meant that she ignored Jeremy’s partner
in the consultation:
..the one consultant at Anycity hospital was
uncomfortable …I felt as though she didn’t know how
to deal with a gay couple. She was uncomfortable with
us …she wouldn’t talk to us, she would sort of talk to
me, but Barry …might as well not have been in the
room…her manner was cold, and I felt the way that
she delivered what was virtually a death sentence
(Jeremy, gay man, prostate).
In these latter experiences, participants were denied
complete access to the salutogenic resource embodied
by their partner or carer. If the partner’s role is not
acknowledged, they may be less likely to play a part in
making sense of a diagnosis or comprehending treat-
ment plans. By contrast, experiences of validation draw
on salutary factors in cancer care, most notably the
desired outcomes of ‘reassurance of worth’ (as an LGB
person with cancer), providing opportunities for ‘nurtur-
ing’ and laying the foundations for a ‘reliable alliance’
with their carer in promoting recovery and quality of life
[25]. There were, however, several instances where part-
ners were validated by health professionals and the rela-
tionship was quietly accepted or openly acknowledged.
Creating safe, salutogenic healing environments
conducive to disclosure
Recent work on salutogenesis has considered how ele-
ments of both the interpersonal and material environment
of hospitals can profoundly shape the extent to which
cancer care is delivered in what have been described as
‘optimal healing environments’ (Jonas et al., 2014). Many
of our participants in the study scanned the environment
for visible clues about the hospital ethos, looking for signs
of its commitment to equality and diversity:
I want to recover and I don’t want the issues [of
homophobic prejudice]…Maybe I am the only one who
thinks that having a little rainbow flag matters, but it
does, and you think oh great, I am not going to have to
give a thought about this (Corinne, lesbian, breast).
The presence of a sign or symbol has the potential to
act as a visual reassurance of a salutogenic environment
for participants; Corinne, said she would be assured that
she would not encounter poor reactions from staff
meaning that she could then focus on her recovery.
However, the hospital appeared not to display any mate-
rials to indicate its policy on inclusivity, despite it being
a major cancer centre serving a city noted for its large
LGB community. For another participant, the lack of a
visible healing-oriented optimal environment meant that
he went back into the closet:
I was in this strange alien environment is how I
viewed it, there was nothing there to reassure me that
I would be OK being myself. I am out in every other
aspect of my life I went back in the closet for this
(Julian, gay man, prostate).
By contrast, another participant pointed to a symbol
worn by a member of staff as evidence of an optimal
healing environment:
Whilst I was in hospital there was a girl there who
had a rainbow tie…it would have been nice…to have
had more things around that were identifiably LGBT.
(Ellie, lesbian, breast).
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Ellie was reassured because one member of staff felt
sufficiently comfortable to wear the rainbow symbol.
Through this she inferred acceptance from the wider
team. Markers of an LGB presence and especially a visu-
ally identifiable commitment to rights, however small,
were very important on participants’ sense of ease. The
lack of such symbols, reported in almost all hospital
contexts, had the potential to make participants feel not
fully safe. For some it influenced their nondisclosure
thus denying them access to full psychosocial support.
Alongside a lack of visible signs of equality indicators,
some participants overheard casual conversations in-
cluding homophobic discourse amongst staff which had
an impact on perceived levels of safety:
And I’d had a few… they weren’t directed at me but
throwaway remarks ….just generally about gay blah
blah blah (Julian, gay man, prostate).
Several participants experienced greater discomfort in
public environments, such as waiting rooms or hospital
wards, which involved contact with other patients. They
described the atmosphere as ‘a bit of awkwardness’ or
‘you don’t quite fit with the normal things that they say
and do’ or they often chose to close down conversations
about family relationships and children. In particular,
several of the gay and bisexual men in the study
described feeling vulnerable and threatened by the
atmosphere on all-male wards:
And so they put me in the orthopaedic ward and I felt
really, really threatened by being with a whole load of
extremely macho men… I didn’t like that at all and so I
went back into the closet straight away. And so it led to
things like, I said to Matthew, (his partner) don’t kiss
me. And …I even encouraged him…you needn’t bother
to come and visit (Rudy, gay man, breast).
Although Rudy’s concerns relate to an anticipated rather
than enacted prejudice, his sense of threat from other pa-
tients undermined his earlier strongly articulated commit-
ment to disclosure. For him, the wider hospital
environment meant that he was not able to benefit from
visits by his partner. Thus, he elects to distance himself
from a key salutogenic resource (the social support pro-
vided by regular visits from his long-term partner) at a
time when he is both physically and psychologically at his
most vulnerable. Other participants also commented on
how visiting times on a hospital ward were occasions
where sexual orientation became visible. Ellie describes
her discomfort about being visited by lesbian couples:
I don’t think I did (disclose) particularly. I think the
thing is the people that were visiting me …. they
come in couples ...so I think anybody who was
looking after me would know that I was a lesbian
(Ellie, lesbian, breast).
Public displays of affection (such as hugging or
kissing) were constrained by the presence of other
patients; gestures of affection were typically minimised
(especially amongst male participants) while other par-
ticipants noted that their affection was not expected by
other patients:
when you come into hospital and they (your partner)
give (s) you a peck on the lips, and I think that’s an
interesting thing for other people in the ward.
Because maybe they are not expecting it (Corinne,
lesbian, breast).
For Lou, being in a same-sex relationship meant that
her partner was able to have additional access to spend-
ing time with her on a single sex ward when male part-
ners were not allowed. Nevertheless, she describes
constraining their behaviour ‘so we wouldn’t have caused
any noise or trouble’.
Whilst many participants discussed feeling uncomfort-
able under a heterosexist ‘gaze’ of fellow patients, some par-
ticipants disclosed positive experiences where their partner
and their children were acknowledged by other patients.
Participants were unable to recall any visible LGB-
affirmative symbols in the hospitals where they received
treatment although smaller markers of inclusivity were
occasionally signalled by individual health professionals.
For some participants, low key acceptance provided assur-
ance that they would not encounter prejudicial attitudes,
while others preferred a brief, positive acknowledgement
of their identities. Although no participant expressed con-
cern about their medical treatment, generally the environ-
ments described by participants could not be described as
‘optimal healing environments’.
Discussion
The study makes a contribution to the emerging body of
literature on sexual orientation disclosure in cancer care
[26, 27]. While the literature has focussed on the need
for disclosure in countering the presumption of hetero-
sexuality [28], this study articulates the salutogenic po-
tential of disclosure for LGB patients in enhancing
quality of life and recovery. Below we revisit each of our
themes and consider their relevance of our findings for a
nuanced approach to understanding disclosure in
secondary care.
Authenticity in cancer care
Previous studies have suggested that many LGB patients
only disclose their sexual orientation if they perceive
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relevance for the treatment of their cancer; moreover,
this is more likely if their cancer is related to sexual or
gynaecological health [5]. Yet, a recent study in Scotland
found that 40% of men who have sex with men believed
that sexual orientation was not relevant in primary care
[29]. While sexual behaviour and health are significant
in the lives of LGB people, many construct their
identities in a multi-dimensional way including: identity
(perceptions of self ), desire (who one is attracted to and
preferred sexual behaviours) and community (social sup-
port and connectedness to others) [30]. The association
of disclosure with sexual health to the exclusion of other
dimensions of identity may result in a narrowly defined
conception of LGB people’s sense of self. Authenticity in
cancer care may only be possible if patients are sup-
ported in incorporating their multifaceted complexities
rather than a reductionist view that posits LGB identities
as solely located in sexual behaviours. Being authentic
then is a foundation for the giving and receiving of
holistic, inclusive, person-centred or comprehensive care
which enables the health professional to take account of
the physical, emotional, psychological and social needs
of the individual and the impact of cancer on their cap-
acity for self-care to promote well-being and recovery
[31]. Our interpretation of the findings in this study are
that sexual orientation is always relevant and is funda-
mental to achieving authenticity, but only if disclosure is
responded to positively. The UK Department of Health’s
flagship assessment of LGB patient experience found
differences on 24 measures including disagreement with
the statement ‘I never felt treated like a set of symptoms
rather than a whole person’ [32]. If a patient feels that
their cancer is treated without regard for them as a whole
person, they may feel that the cancer professional is solely
concerned with treating their disease or has not consid-
ered that treatment options might affect them differently
[33]. These data are confirmed in a study of cancer pa-
tients’ priorities, wherein participants rated the manage-
ment of practical, social and emotional issues as a higher
priority than biological and treatment aspects [34].
The partner as a potential salutogenic resource
In the wider literature, partners can play a key role in
gathering information and form part of the triad in the
consultation process [35]. This study, which evaluated
the degree to which opposite sex partners of prostate
cancer patients participated in shared decision-making,
showed that the doctor encouraged the spouse to par-
ticipate and found, among several benefits, strong asso-
ciations between satisfaction with treatment options and
the active participation of the partner or carer.
Our findings that the presence of a partner can act as
a prompt to sexual orientation disclosure to a profes-
sional confirms other findings in the literature [36] and
can thus promote self-actualisation and authenticity. But
the distinctive contribution of the findings lies in partici-
pants’ recognition that validation of their relationship
helps them to feel at ease and accepted. Moreover, the
findings point to generalised resistance resources such
as helping to make treatment decisions and greater
awareness of the social support a partner may provide.
Creating safe, salutogenic healing environments
conducive to disclosure
The presence of visible symbols to signal that a hospital
is dedicated to providing comprehensive care was per-
ceived to be lacking by participants in this study. There
were circumstances where individual health profes-
sionals wore a brooch or a tie, but there were no exam-
ples of a whole system approach to LGB inclusion.
Public areas within hospital settings appeared to present
some tensions such as in waiting rooms and on hospital
wards where participants were concerned about reac-
tions from other patients. In these environments, they
were constrained by feeling unable to seek reassurance
by a hug or a kiss. These findings support prior research
which has shown a lack of culturally competent care
reflected in patient intake forms, provider-patient com-
munication and confidentiality [37]. While several
participants were prepared to discuss the impact of
treatment for prostate cancer for their future sexual rela-
tionships, some participants felt that this was an
additional responsibility which they did not want to
undertake confirming findings elsewhere [38]. There
were few examples of homophobic remarks, but they
created an alien environment. LGB affirmative care sym-
bols, then, represent more than a token gesture and
would indicate to LGB patients that staff were trained
and committed to providing an inclusive service [39]. It
would also mean that health professionals were aware of
current marriage legislation so that the status of a rela-
tionship is not contested. These issues problematise the
notion of comprehensive care; in common understand-
ings, equality in care is taken to mean: ‘I provide the
same care for everyone’, the objective for quality health-
care is equity and not sameness [40, 41]. The findings
illustrate some of the complexities of facilitating disclos-
ure. Some of our study participants expressed the prefer-
ence for staff to be openly LGB affirmative, but they did
not always want other patients to know. This is some-
thing of a paradox in the creation of LGB clinical
friendly spaces.
Limitations
This study has a number of limitations which may be
reflected in the sample: there is some evidence to sug-
gest the majority of LGB people live alone [42], but in
our sample four-fifths were partnered. We were unable
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to recruit LGB people from Black and Minority Ethnic
communities or bisexual women. Participants were re-
cruited through hospital trusts which had already pro-
vided LGB equality and diversity training for staff and
who might be expected to be more likely to take inclu-
sive approaches to care. Participants were also recruited
through cancer support groups and were therefore more
likely to be open about their sexual orientation and to
consider it relevant to their care. The study is not
intended to represent the experiences of all LGB patients
with cancer, but to present detailed first-hand accounts
about how participants manage disclosure to health
professionals, their perceptions about the relevance and
value of disclosure to their sense of self and their experi-
ence of care and their responses to the hospital as a
potentially healing environment.
Conclusion
In conclusion, this study illustrates three domains with
health generating potential for LGB patients with cancer:
promoting authenticity in healthcare interactions;
involving a partner or carer in the cancer care pathway
and the creation of healing environments. Taken
together, the three domains constitute a salutogenic
orientation for LGB cancer care. Such an orientation of
necessity asks: ‘how can this person be helped to move
toward greater health in all aspects of their humanity?’
Recognition of this principle would enable professionals
to facilitate disclosure or to create optimal healing envi-
ronments which would benefit those patients who did
not see the need. Creating the conditions which signal
inclusivity and allow for the possibility of disclosure con-
tribute to moving LGB people to greater health, whether
or not they are able to disclose. Further research which
asks professionals about strategies to achieve these out-
comes is needed.
Recommendations
The study findings first highlight the need for training of
all staff where they are able to facilitate disclosure, make
a positive response and promote understanding of its
health benefits. Rather than the individual markers of in-
clusivity noted by participants, the study recommends a
whole system approach across secondary care in the
NHS. In the USA, the healthcare equality index confers
an award to healthcare organisations which acts a kite-
mark of quality assurance. In the UK, localised projects
have introduced similar initiatives in primary care, but
no England-wide initiative currently exists to support
this work in hospital settings. Second, the recognition of
partners or carers as a salutogenic resource in the care
pathway can contribute to promoting quality of life.
Third, the creation of LGB healing environments where
visible symbols of inclusion act as quality assurance
mechanisms that staff are knowledgeable about LGB
cancer care and have the skills and confidence to sup-
port health promoting outcomes. In these environments,
health organisations will have worked to eradicate
homophobic discourse and develop settings where LGB
patients are fully comfortable in receiving visits from
family and friends. These are all key processes that need
to be developed in ensuring that LGB people feel fully
satisfied with their care.
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